Ascelia Pharma AB

← The SEC Ephemeris: the whole map

Ascelia Pharma AB

In the graph: all 1 documents (2 pages).

Application: NDA 220544
Ticker: Ascelia Pharma AB
Disease area: Not yet classified
Response path: Not yet classified
Complete Response Letters: July 2, 2026

From FDA letters and SEC filings. Not investment or medical advice.

Not yet classified

AFT Pharmaceuticals Ltd. sirolimus
Agile Therapeutics, Inc. levonorgestrel/ethinyl estradiol
Akebia Therapeutics, Inc. vadadustat
Akeso Biopharma Co., Ltd. AK105
Alkermes, Inc. Lybalvi
Almatica Pharma, LLC zolpidem tartrate
Althera Life Sciences, LLC rosuvastatin
Alvotech USA Inc. AVTO5
Amgen Inc. Kanjinti
Amneal EU, Limited phenylephrine hydrochloride
Amphastar Pharmaceuticals, Inc. We also acknowledge receipt of your amendment dated as SP which was not reviewed
Amryt Pharmaceuticals DAC Filsuvez
Antares Pharma, Inc. hydrocortisone sodium phosphate
AOP Orphan Pharmaceuticals GmbH landiolol
Apiject Systems Corp. glycopyrrolate
Applied Therapeutics, Inc. govorestat
Aquestive Therapeutics Inc. dibutepinephrine
Ardelyx, Inc. tenapanor hydrochloride
Armstrong Pharmaceuticals Primatene Mist
ARS Pharmaceuticals, Inc. Neffy
Ascelia Pharma AB
Ascendis Pharma Bone Diseases A/S palopegteriparatide
Astellas Pharma US, Inc. IZERVAY
AstraZeneca AB Breztri Aerosphere
AstraZeneca Pharmaceuticals LP anifrolumab
Atara Biotherapeutics, Inc. tabelecleucel®) @)
AuroMedics Pharma LLC Cyclophosphamide
AVEO Pharmaceuticals, Inc. tivozanib hydrochloride
Azurity Pharmaceuticals, Inc. sitagliptin
B. Braun Medical, Inc. Acetaminophen
Bausch Health Ireland Limited fluorescein sodium
Baxter Healthcare Corporation DAPZURA RT
Bayer HealthCare LLC Naproxen sodium
Belcher Pharmaceuticals, LLC. Ablysinol
BendaRx USA Corporation bendamustine
Bio-Thera Solutions Ltd. BAT1706
Biogen, Inc.
Biohaven Therapeutics, Ltd. troriluzole
Bioprojet Pharma Wakix
Bioverativ USA, Inc. sutimlimab

All 283 on the full map →

Group by

Build queue · replay at pipeline speed